Learn About Leishmaniasis

What is the definition of Leishmaniasis?

Leishmaniasis is an infectious disease spread by the bite of the female sandfly.

What are the alternative names for Leishmaniasis?

Kala-azar; Cutaneous leishmaniasis; Visceral leishmaniasis; Old world leishmaniasis; New world leishmaniasis

What are the causes of Leishmaniasis?

Leishmaniasis is caused by a tiny parasite called leishmania protozoa. Protozoa are one-celled organisms.

The different forms of leishmaniasis are:

  • Cutaneous leishmaniasis affects the skin and mucous membranes. Skin sores usually start at the site of the sandfly bite. In a few people, sores may develop on mucous membranes.
  • Systemic, or visceral, leishmaniasis affects the entire body. This form occurs 2 to 8 months after a person is bitten by the sandfly. Most people do not remember having a skin sore. This form can lead to deadly complications. The parasites damage the immune system by decreasing the numbers of disease-fighting cells.

Cases of leishmaniasis have been reported on all continents except Australia and Antarctica. In the Americas, the disease can be found in Mexico and South America. It has also been reported in military personnel who have returned from the Persian Gulf.

What are the symptoms of Leishmaniasis?

Symptoms of cutaneous leishmaniasis depend on where the lesions are located and may include:

  • Breathing difficulty
  • Skin sores, which may become a skin ulcer that heals very slowly
  • Stuffy nose, runny nose, and nosebleeds
  • Swallowing difficulty
  • Ulcers and wearing away (erosion) in the mouth, tongue, gums, lips, nose, and inner nose

Systemic visceral infection in children usually begins suddenly with:

  • Cough
  • Diarrhea
  • Fever
  • Vomiting

Adults usually have a fever for 2 weeks to 2 months, along with symptoms such as fatigue, weakness, and appetite loss. Weakness increases as the disease gets worse.

Other symptoms of systemic visceral leishmaniasis may include:

  • Abdominal discomfort
  • Fever that lasts for weeks; may come and go in cycles
  • Night sweats
  • Scaly, gray, dark, ashen skin
  • Thinning hair
  • Weight loss
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Leishmaniasis?

Antimony-containing compounds are the main medicines used to treat leishmaniasis. These include:

  • Meglumine antimoniate
  • Sodium stibogluconate

Other medicines that may be used include:

  • Amphotericin B
  • Ketoconazole
  • Miltefosine
  • Paromomycin
  • Pentamidine

Plastic surgery may be needed to correct the disfigurement caused by sores on the face (cutaneous leishmaniasis).

Who are the top Leishmaniasis Local Doctors?
Naomi E. Aronson
Elite in Leishmaniasis
Infectious Disease
Elite in Leishmaniasis
Infectious Disease
Walter Reed Army Medical Center, 6900 Georgia Ave Nw, 
Washington, DC 
Languages Spoken:
English

Naomi Aronson is an Infectious Disease provider in Washington, Washington, D.c.. Dr. Aronson is rated as an Elite provider by MediFind in the treatment of Leishmaniasis. Her top area of expertise is Leishmaniasis.

Elite in Leishmaniasis
Elite in Leishmaniasis
Salvador, BA, BR 

Edgar Carvalho practices in Salvador, Brazil. Mr. Carvalho is rated as an Elite expert by MediFind in the treatment of Leishmaniasis. His top areas of expertise are Leishmaniasis, HTLV-1 Associated Myelopathy, Schistosomiasis, and Distomatosis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Leishmaniasis
Elite in Leishmaniasis
No. 25, Kynsey Road, 
Colombo, LK 

Nadira Karunaweera practices in Colombo, Sri Lanka. Ms. Karunaweera is rated as an Elite expert by MediFind in the treatment of Leishmaniasis. Her top areas of expertise are Leishmaniasis, Malaria, and Glucose-6-Phosphate Dehydrogenase Deficiency.

What is the outlook (prognosis) for Leishmaniasis?

Cure rates are high with the proper medicine, mostly when treatment is started before it affects the immune system. Cutaneous leishmaniasis may lead to disfigurement.

Death is usually caused by complications (such as other infections), rather than from the disease itself. Death often occurs within 2 years.

What are the possible complications of Leishmaniasis?

Leishmaniasis may lead to the following:

  • Bleeding (hemorrhage)
  • Deadly infections due to immune system damage
  • Disfigurement of the face
When should I contact a medical professional for Leishmaniasis?

Contact your provider if you have symptoms of leishmaniasis after visiting an area where the disease is known to occur.

How do I prevent Leishmaniasis?

Taking measures to avoid sandfly bites can help prevent leishmaniasis:

  • Putting fine mesh netting around the bed (in areas where the disease occurs)
  • Screening windows
  • Wearing insect repellent
  • Wearing protective clothing

Public health measures to reduce sandflies are important. There are no vaccines or medicines that prevent leishmaniasis.

What are the latest Leishmaniasis Clinical Trials?
Host Response to Infection and Treatment in Leishmania Infection of Humans

Summary: This study will examine the natural history of Leishmanial infections and their treatments. It will provide an opportunity for NIAID staff to learn more about leishmaniasis and perhaps to improve diagnostic tests for these infections. Patients between 2 and 80 years of age with known or suspected leishmaniasis are eligible for this study. Participants will have routine blood tests and a biopsy to ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Effectiveness of Ciprofloxacin Intralesional Injection in the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate: a Parallel Groups Comparative Trial

Summary: The Aim of the trial to evaluate the effectiveness of intralesional ciprofloxacin 0.2% solution as a local injection in treating cutaneous leishmaniasis and compare its effect with intralesional sodium stibogluconate (SSG) 10% intravenous solution in cutaneous leishmaniasis as a local injection. In a randomized parallel groups clinical trial, patients were divided into two groups based on therapeu...

Who are the sources who wrote this article ?

Published Date: August 26, 2023
Published By: Jatin M. Vyas, MD, PhD, Roy and Diana Vagelos Professor in Medicine, Columbia University Vagelos College of Physicians and Surgeons, Division of Infectious Diseases, Department of Medicine, New York, NY. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Aronson NE, Copeland NK, Magill AJ. Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier; 2020:chap 275.

Dinulos JGH. Infestations and bites. In: Dinulos JGH, ed. Habif's Clinical Dermatology. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 15.